Next-generation Immunotherapies for Cancer
Our laboratory focuses on the study of the mechanisms of relapse after chimeric antigen receptor T cell (CART) immunotherapy with the goal of rationally design innovative next-generation immunotherapies for relapsing/refractory leukemia and lymphoma.
We're looking for a bioinformatician to join our lab! If you're interested, please see link for job details. University of Pennsylvania - Careers@Penn